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Clinical Practice Variability in Temperature Correction
of Arterial Blood Gas Measurements and Outcomes
in Hypothermia-Treated Patients After Cardiac Arrest
Samuel Waller Terman, MD, MS,1,2 Katherine S. Nicholas, BA,3
Benjamin Hume, BS,1 and Robert Silbergleit, MD1
Mechanical ventilation in patients treated with mild therapeutic hypothermia (MTH) for the postcardiac arrest
syndrome may be challenging given changes in solubility of arterial blood gases (ABGs) with cooling. Whether
ABG measurements should be temperature corrected (TC) remain unknown. We sought to describe practice
variability in TC at a single institution and explored the association between TC and neurological outcome. We
conducted a retrospective cohort study reviewing electronic health records of all patients treated with MTH
after cardiac arrest. We examined whether the percentage of TC ABGs relative to total number of ABGs drawn
for each subject during hypothermia was associated with the neurological outcome at hospital discharge and
6–12-month follow-up. The cerebral performance category of 1–2 was defined as a favorable outcome in the
logistic regression models. 1223 ABGs were obtained during MTH on 122 subjects over 6 years. TC was never
used in 72 subjects (59%; no TC group), made available in 1–74% of ABGs in 17 subjects (14%; intermediate
TC group), and made available inq75% of ABGs in 33 subjects (27%; mostly TC group). Groups differed in
the proportion of subjects with shockable presenting rhythms (47% vs. 47% vs. 76%, p= 0.02) and admitting
ICU ( p = 0.005). Favorable 6-month outcomes were more common in the mostly TC than no TC group (48% vs.
25%; OR [95% CI]: 2.9 [1.2–7.1]), but not after adjustment (OR 1.5, 95% CI 0.33–6.9). There was substantial
practice variability in the temperature correction strategy. Availability of temperature-corrected ABGs was not
associated with improved neurological outcomes after adjusting for covariates.
Introduction
Over 380,000 emergency medical services- (EMS-)treated nontraumatic out-of-hospital cardiac arrests
(OHCA) occur each year in the United States, with an estimated
overall survival to hospital discharge with at least a moderate
neurological outcome of 6.9% (McNally et al., 2011; Roger
et al., 2012). Recent data from a large randomized trial showed
similar outcomes in patients cooled to two controlled subfebrile
temperatures, 33C versus 36C, following OHCA (Nielsen
et al., 2013). In previous trials, mild therapeutic hypothermia
(MTH) to 33C was shown to benefit selected patients when
compared with no temperature control (Bernard et al., 2002;
Hypothermia after Cardiac Arrest Study Group, 2002; Peberdy
et al., 2010; Arrich et al., 2012). Proper ventilatory support is
considered important to successful postcardiac arrest man-
agement (Peberdy et al., 2010; Schneider et al., 2013), espe-
cially given the potential for iatrogenic dyscarbia (Falkenbach
et al., 2009) and its effect on outcomes (Schneider et al., 2013).
However, there is equipoise on how this should be achieved in
hypothermic patients (Hoedemaekers and van der Hoeven,
2014). As temperature decreases, the solubility of arterial
blood gases (ABGs) increases, partial pressures of oxygen and
carbon dioxide decrease, and pH rises (Alston, 2004). Venti-
lator management depends on how these changes are ac-
counted for when measuring and reporting ABGs. Alternative
approaches include pH-stat in which ABGs are temperature
corrected (TC) and a-stat in which measurements are always
evaluated at 37C (Alston, 2004; Bisson and Younker, 2006).
There is practice variation over whether or not to employ
TC values when measuring ABGs during MTH (Bisson and
Younker, 2006). The importance of these differences upon
clinical outcomes in patients with relatively mild cooling
after cardiac arrest has been incompletely evaluated, but
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remains plausible, given the sensitivity of the injured brain to
PaCO2-dependent cerebral blood flow, changes in oxygen
delivery and metabolism, and possibly to other electro-
chemical pertubations (Yundt and Diringer, 1997; Ausina
et al., 1998).
The objectives of the present study are to describe practice
variability in TC at a single institution and to use such
practice variability to explore the association between TC
and outcome. We hypothesize that practice variation exists
even within a single institution and that such variation in TC
practice will be associated with differences in outcomes.
Materials and Methods
Study design
This was an observational retrospective cohort study
(Vandenbroucke et al., 2007). Subjects were classified by the
percentage of ABGs with TC available (i.e., pH-stat) relative
to the total number of ABGs drawn for each subject during
hypothermia therapy. The main comparison constituted those
with at least 75% of ABGs including TC values (dubbed the
mostly TC group), versus those with 0% of ABGs including
TC values (i.e., 100% using a-stat, dubbed the no TC group).
Those subjects with 1–74% of ABGs including TC values are
dubbed the intermediate TC group.
Subject selection
Electronic health records were screened for all patients
presenting to the University of Michigan Emergency Depart-
ment with a presentation or diagnosis coded as OHCA, fol-
lowing implementation of our MTH program between August
26, 2006, and September 14, 2012. To ensure that we captured
all eligible subjects, we also screened patients included on an
independent log of therapeutic temperature management
(TTM) equipment use. All included subjects were comatose,
endotracheally intubated, and mechanically ventilated. Pa-
tients were excluded if they were younger than 18 years at the
time of arrest, received temperature management therapy for a
diagnosis other than cardiac arrest (i.e., rewarming after en-
vironmental hypothermia), if cooling was withdrawn imme-
diately after implementation, or if no ABGs were available.
Subjects were typically admitted to either a Cardiac Intensive
Care Unit (CICU) or a Critical Care Medical Unit (CCMU)
depending on the suspected etiology of the cardiac arrest.
Therapeutic hypothermia
MTH at our institution consisted of endovascular cooling
(Innercool; Phillips, San Diego, CA) for 24 hours at a target
of 33C followed by controlled rewarming over 24 hours
back to normothermia. Placement of the endovascular tem-
perature control catheter typically occurred in the Emergency
Department, but sometimes occurred in the interventional
cardiology suite, or the ICU depending on the clinical situ-
ation. Cold intravenous crystalloid bolus was allowed to
initiate cooling if placement of the catheter was delayed.
Ventilation protocol
Our institution executes a standard ventilation protocol
managed by respiratory therapists. According to the protocol,
ventilator frequency and/or tidal volumes were adjusted to
maintain a pH of 7.30–7.45 for most patients, except those
with obstructive lung disease or ARDS may be ventilated
with permissive hypercapnia to maintain a peak plateau level
<30 cm H20. FiO2 was titrated for SpO2 of 90–94%.
Data collection and outcomes assessment
This project was reviewed and determined exempt by the
University of Michigan Institutional Review Board. Data
collection was based on Utstein recommendations ( Jacobs
et al., 2004) and performed according to reported standards in
chart review research (Gilbert et al., 1996).
All data were abstracted from the University of Michigan
electronic health records by the primary author (S.T.). The
author conducting the analysis was not blinded to the study
purpose or any part of the data. We reviewed and included all
ABGs drawn during hypothermia therapy from the start of
cooling induction to completion of rewarming. Details re-
garding demographics, medical history, the event and resus-
citation, including shockable rhythm and time to reaching the
target temperature of 33C, hypothermia protocol, and dis-
charge vital status were also determined. Being classified as
shockable means that an automatic external defibrillator was
applied, which advised a shock, or the emergency department
(ED) or emergency medical services (EMS) flowsheets/
runsheets mark the presenting arrest rhythm as either ven-
tricular fibrillation (VF) or pulseless ventricular tachycardia
(VT). Being classified as nonshockable means it was docu-
mented that an automated external defibrillator (AED) did not
advise a shock, ED or EMS flowsheets/runsheets specify
pulseless electrical activity (PEA) or asystole as the present-
ing cardiac rhythm, or else presenting rhythm and defibrilla-
tion are not specifically mentioned, but there exists sufficient
medical documentation detailing resuscitative efforts such
that it would be reasonable to assume that a defibrillation
would have been documented if it had been delivered.
APACHE II scores were calculated on best available
data. Laboratory values at admission were used to calculate
APACHE II scores (Knaus et al., 1985; Ho et al., 2006). Vital
signs at admission were used as well, except for temperature
that was frequently missing on arrival. For consistency, the
lowest temperature achieved during cooling was used.
Data were collected and managed using REDCap (Re-
search Electronic Data Capture) electronic data capture tools
hosted by the University of Michigan (Harris et al., 2009).
We determined whether ABGs included TC based on
laboratory records in the electronic health record. A tem-
perature listed for each blood gas of 37C or else no tem-
perature listed indicates that gases were run without TC.
ABGs were determined to be TC for hypothermia if their
laboratory documentation indicated a temperature below
37C. Corrected readings were obtained by applying math-
ematical formulas to the uncorrected reading to approximate
partial pressures at a hypothermic temperature. All ABGs
that have corrected readings also have uncorrected readings
listed in the medical record.
Neurological outcomes were characterized by Cerebral
Performance Category (CPC) ( Jennett and Bond, 1975; A
Randomized Clinical Study of a Calcium-Entry Blocker,
1991; Safar and Bircher, 1998). Outcomes were dichoto-
mized as favorable (CPC 1–2, i.e., no symptoms and/or in-
dependence) or unfavorable (CPC 3–5, i.e., dependent,
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comatose, or dead) at hospital discharge and 6–12 months
postdischarge. Outcomes were determined by reviewing in-
patient and outpatient physician and physical/occupational
therapy evaluations. Determination of CPC from chart re-
view has been previously determined to have moderately
good correlation with that determined by patient interview
(Raina et al., 2008). CPCs were determined by two inde-
pendent reviewers (S.T. and R.S.). Initial inter-rater agree-
ment was 85% and 73% for nondeceased CPCs at discharge
and follow-up, respectively, and when discordant, resolved
by consensus. We used the first note after 6 months that
provided sufficient information relevant to neurological
symptoms on which to base our assessment. If no informative
note existed in the relevant time interval but medical records
indicated a consistent CPC before and after the interval of
interest without mention of significant intervening event,
such records were incorporated. If no such note existed or the
subject was lost to follow-up from the University of Michigan
electronic records, they were recorded as having a missing
CPC. If the 6-month vital status was unavailable from med-
ical records, we searched the Social Security Death Index
Master File (accessed 5/14/2013).
Statistical analysis
Descriptive statistics were used to characterize the cohort.
Continuous variables were described using medians and in-
terquartile ranges. Categorical variables were described as
absolute frequencies. To account for the fact that ABGs were
drawn repeatedly over time, we have compared ABG mea-
surements between groups using a generalized estimating
equation with a repeated measures structure. Chi-squared
tests and logistic regressions were used to determine asso-
ciations between categories of proportion of ABGs that were
temperature corrected and dichotomized CPC outcomes.
Our initial primary prespecified comparison was to com-
pare those with all TC readings to those with no TC readings.
However, given relatively few subjects with all pH-stat
readings, our primary analysis was modified to compare 0%
(no TC) versusq75% (mostly TC) available pH-stat read-
ings. In further analysis, we incorporated the intermediate TC
group (1–74% ABGs pH-stat) in our logistic regression in
comparison to the no TC group. Covariates were included as
potential confounders in our adjusted logistic regressions by
being associated with the main TC category, the outcome
variables, or conceptually important despite no significant
association with either variable.
Results
Baseline characteristics
The population screened included 491 adult patients pre-
senting with OHCA between 2006 and 2012 through the
University of Michigan Emergency Department (Fig. 1). Of
these, 134 had return of spontaneous circulation (ROSC) and
were considered candidates for targeted temperature man-
agement; 123 of these had cooling initiated. Of the 123, 1 had
no ABGs available, so 122 met criteria and were ultimately
included for analysis. Of the 122 included subjects, 118
(97%) were known to reach a temperature ofp34C.
Baseline characteristics are displayed in Table 1. Groups are
similar, except subjects differed between the TC groups ac-
cording to the proportion presenting with shockable rhythms
( p= 0.02) and admitting ICU ( p= 0.005).
Thirty-eight percent of the CICU subjects were catego-
rized in the mostly TC group, as opposed to 12% of the
CCMU subjects (Table 2, p = 0.003). There was no difference
in the number of ABGs collected per subject by the ICU
category ( p = 0.29). Subjects in the two major ICU categories
also differed by etiology of arrest ( p < 0.001) and shockable
presentation ( p < 0.001) (Table 2).
ABG measurements
In total, we obtained 1223 ABGs (median [IQR]: 10 [7–13]
per subject) from 122 subjects, of which 358 (29%) included
TC. The distribution in the proportion of ABGs that were TC
per subject is displayed in Figure 2.
FIG. 1. Subject Selection.
ABGs, arterial blood gases;
ED, emergency department;
OHCA, out-of-hospital car-
diac arrests; ROSC, return of
spontaneous circulation; TC,
temperature corrected; TTM,
therapeutic temperature
management.
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Average ABG measurements are listed in Table 3. Carbon
dioxide (CO2) measurements were a mean (95% CI) 5.7 (2.9–
8.5) mmHg lower after correction, and CO2 readings differed
according to the group ( p < 0.0001). Other values did not
significantly differ according to group.
Neurological outcomes
Table 4 shows outcomes by group in this cohort. No subject
had a missing discharge vital status. In the no TC group, 1 (1%)
and 7 (10%) had missing discharge and follow-up CPCs, re-
spectively. In the mostly TC group, 0 (0%) and 2 (6%) had
missing discharge and follow-up CPCs, respectively. No
subject in the intermediate TC group had a missing CPC.
In unadjusted analysis, the intermediate TC group dem-
onstrated lower odds of hospital survival than the other two
groups (OR, 95%: 0.21, 0.04–0.99 compared with the no TC
group). Survival did not differ between the mostly TC and no
TC groups. The mostly TC group had higher odds of a fa-
vorable CPC at both discharge and follow-up than the other
two groups.
In Table 4, we adjusted for whether the presenting rhythm
was shockable, age, sex, history of diabetes and congestive
heart failure, APACHE II score, etiology, and ICU. Survival
Table 1. Baseline Characteristics
No TC group
(n = 72)
Intermediate TC
group (n= 17)
Mostly TC
group (n = 33) p
Age, years, median (IQR) 59 (52–72) 63 (53–78) 62 (52–67) 0.59
BMI, median (IQR) 27 (23–32) 28 (24–32) 28 (26–30) 0.53
Sex, male, n (%) 48 (67) 10 (59) 22 (67) 0.82
PMH, n (%)
MI 11 (15) 5 (29) 7 (21) 0.38
CHF 12 (17) 5 (29) 2 (6) 0.09
TIA or strokea 7 (10) 3 (18) 5 (15) 0.53
Dementia 2 (3) 0 (0) 0 (0) > 0.99
DM 21 (29) 5 (29) 5 (15) 0.28
Dialysis 6 (8) 2 (12) 1 (3) 0.37
Witnessed, n (%)
Yes 56 (78) 14 (82) 27 (82) 0.65b
No 16 (22) 2 (12) 6 (18)
Unknown 0 (0) 1 (6) 0 (0)
Bystander CPR, n (%)
Yes 51 (71) 9 (53) 25 (76) 0.36b
No 20 (28) 7 (41) 8 (24)
Unknown 1 (1) 1 (6) 0 (0)
Etiology, n (%)
CV 14 (19) 4 (24) 12 (36) 0.42
Respiratory 9 (13) 3 (18) 1 (3)
Unknown 38 (53) 8 (47) 15 (45)
Otherc 11 (15) 2 (12) 5 (15)
Shockable presenting rhythm, n (%)d 34 (47) 8 (47) 25 (76) 0.02
ICU, n (%)e
CICU 33 (45) 11 (65) 27 (81) 0.005
CCMU 37 (51) 6 (35) 6 (18)
Other 2 (3) 0 (0) 0 (0)
APACHE II, median (IQR)f 28 (24–32) 30 (28–33) 26 (22–30) 0.17
ABGs per patient, median (IQR) 10 (7–14) 9 (6–11) 9 (7–13) 0.3
Time to target, hours, median (IQR)g 5.9 (3.5–8.4) 6.6 (5.5–8.2) 4.8 (3.1–6.7) 0.5
Withdrawal of life support, n/No. of died (%)h 37/44 (84) 13/15 (87) 11/16 (73) 0.69
aIncludes ischemic or hemorrhagic stroke or TIA.
bp-Value excluding unknown category.
cIncludes intoxication (1 a-stat group, 3 pH-stat group), electrolyte disturbance (2 a-stat group), trauma (1 a-stat group), hanging (2 a-stat
group), electrocution (2 a-stat group, 2 pH-stat group), allergic reaction (1 a-stat group), precipitating seizure (1 a-stat group), sepsis
(1 intermediate group), drowning (1 intermediate group), and precipitating coitus (1 a-stat group).
dIncludes ventricular fibrillation and pulseless ventricular tachycardia. Pairwise comparisons as follows: a-stat versus intermediate
( p > 0.99), a-versus pH-stat ( p = 0.006), and intermediate versus pH-stat ( p = 0.04).
ePairwise comparisons as follows: a-stat versus intermediate ( p = 0.46), a-versus pH-stat ( p = 0.001), and intermediate versus pH-stat
( p = 0.29).
fAcute Physiologic and Chronic Health Evaluation II Score.
gDuration between Emergency Department arrival and consecutive recorded core body temperatures <33.5C.
hAmong those that expired.
ABGs, arterial blood gases; BMI, body mass index; CCMU, Critical Care Medical Unit; CHF, congestive heart failure; CICU, Cardiac
Intensive Care Unit; CPR, cardiopulmonary resuscitation; CV, cardiovascular; DM, diabetes mellitus; IQR, interquartile range; MI,
myocardial infarction; PMH, past medical history; TC, temperature corrected; TIA, transient ischemic attack.
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remained lower in the intermediate TC group compared with
the other two groups (OR, 95%: 0.07, 0.01–0.56 compared
with the no TC group) and still did not differ between the no
TC and mostly TC groups. There were no longer any sig-
nificant differences between groups regarding either dis-
charge or follow-up CPCs.
Several sensitivity analyses were performed. First, we used
different comparison cutoffs. Results were similar whether
we compared 0% (n = 72) versusq75%, as we have done
here, or <25% (n= 74) versusq75%. Second, we reanalyzed
the data as if missing CPCs were either all favorable or
unfavorable. Results were quantitatively and qualitatively
similar to the reported results. Third, we adjusted for a variety
of covariate combinations. Initially, we adjusted only for
presenting rhythm because it was the only factor fulfilling the
statistical definition of a confounder, that is, significantly
associated with both TC groups ( p = 0.02, Tables 1 and 2) and
outcomes (e.g., p < 0.001 for hospital survival). We then
broadened our array of confounders to include any factor
associated with either (1) the TC group [ICU ( p = 0.005)] or
(2) outcomes [for hospital survival: sex ( p = 0.03), diabetes
( p= 0.008), APACHE II score ( p < 0.001)]. We also then
included CHF, given its borderline significant association
with both the TC group ( p = 0.09) and survival ( p= 0.08),
and also etiology, given its clinical and conceptual impor-
tance. We also ran models both including and excluding ICU,
given that because neither subject in the other ICUs had a
favorable CPC, including such a term that commits a quasi-
complete separation of values. We also forced the TC cate-
gory into the model and performed backwards model
selection from the fully adjusted model with staying criteria
of p = 0.05. Ultimately, all adjusted results were both quali-
tatively and quantitatively similar in models where we ad-
justed for only presenting rhythm, the fully adjusted model,
or any subset such as using backwards model selection.
Discussion
Our data confirm that substantial clinical practice variation
exists even at a single institution. Our results also suggest that
availability of TC ABGs was not associated with improved
neurological outcomes after adjusting for covariates. In-
dividuals with a mixture of TC methods (the intermediate TC
group) demonstrated poorer hospital survival than those with
predominantly TC or no TC (Table 4). It is possible that
inconsistency in ventilator management, rather than which
strategy is chosen, is harmful. However, caution is necessary
Table 2. Characteristics by Admitting
Intensive Care Unit
CICU
(n = 71)
CCMU
(n = 49) pa
Age, years,
median (IQR)
63 (54–72) 58 (43–72) 0.11
BMI, median (IQR) 27 (24–30) 28 (24–35) 0.39
Sex, male, n (%) 48 (68) 30 (61) 0.47
PMH, n (%)
MI 17 (24) 6 (12) 0.11
CHF 12 (17) 7 (14) 0.7
TIA or stroke 11 (15) 4 (8) 0.23
Dementia 0 (0) 2 (4) 0.16
DM 15 (21) 16 (33) 0.29
Dialysis 5 (7) 4 (8) > 0.99
Witnessed, n (%)
Yes 60 (85) 35 (71) 0.06
No 10 (14) 14 (29)
Unknown 1 (1) 0 (0)
Bystander CPR, n (%)
Yes 53 (75) 30 (61) 0.12
No 17 (24) 18 (37)
Unknown 1 (1) 1 (2)
Etiology, n (%)b
CV 27 (38) 2 (4) < 0.001
Respiratory 4 (6) 9 (18)
Unknown 37 (52) 24 (49)
Other 3 (4) 14 (29)
Shockable presenting
rhythm
58 (82%) 8 (16) < 0.001
TC category, n (%)
No TC group 33 (46) 37 (76) 0.003
Intermediate
TC group
11 (15) 6 (12)
Mostly TC group 27 (38) 6 (12)
APACHE II,
median (IQR)
27 (22–31) 29 (25–32) 0.06
ABGs per patient,
median (IQR)
10 (7–13) 9 (6–13) 0.29
Time to target,
hours, median (IQR)
5.0 (3.3–7.9) 5.9 (3.8–8.4) 0.11
Withdrawal of life
support, n/No.
died (%)
26/33 (79) 34/40 (85) 0.49
aNote that the other ICU group is not displayed due to a small
number of subjects in that group (n= 2). p-Values compare the CICU
versus CCMU populations. p-Values are calculated from t-tests for
continuous variables (age, BMI, APACHE II, time to target), and
either chi-square or Fisher’s exact tests for categorical variables.
bIncludes intoxication (4 CCMU), electrolyte disturbance (1
CCMU, 1 CICU), trauma, hanging (2 CCMU), electrocution (3
CCMU, 1 CICU), allergic reaction (1 CCMU), precipitating seizure
(1 CCMU), sepsis (1 CCMU), drowning (1 CCMU), and precip-
itating coitus (1 CICU).
FIG. 2. Proportion of TC ABG Distribution. Brackets
delineate our three study groups: the large mode at 0 rep-
resents our no TC group, in which no ABGs were TC
(n= 72), those above 0.75 represent our mostly TC group, in
which at least 75% of each subject’s ABGs included TC
(n= 33), and those in between represent the intermediate TC
group, in which 1–74% of ABGs included TC (n = 17).
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when interpreting results from the intermediate TC group due
to its small sample size (n = 17).
Arguments exist in favor of the pH-stat (TC) method in
terms of cerebral hemodynamics. PaCO2 increases (pH de-
creases) with increasing temperature (Alston, 2004). The
same blood gas analyzed at a corrected temperature (pH-stat),
therefore, appears less acidic (lower PaCO2) than if it were
analyzed without accounting for temperature. A gas that
appears less acidic would theoretically lead to less aggressive
minute ventilation to achieve the same neutral targets. Total
body PaCO2 and cerebral blood flow (CBF) might, therefore,
be higher in a patient ventilated with the pH-stat method
(Kofstad, 1996; Kollmar et al., 2002; Pynnonen et al., 2011)
by avoiding hyperventilation, which would have exerted a
vasoconstrictive effect (Diringer et al., 2002; Imberti et al.,
2002; Coles et al., 2007). Borrowing from literature performed
in other than populations, there are possibly improved out-
comes with pH-stat in hypothermic cardiopulmonary bypass
patients (du Plessis et al., 1997; Laussen et al., 2002) and
increased tissue oxygenation with pH-stat in animal studies
(Duebener et al., 2002; Markowitz et al., 2007; Pirzadeh et al.,
2011). Animal (Kollmar et al., 2002) and human (Kollmar
et al., 2009) studies in ischemic stroke have demonstrated this
phenomenon of reduced cerebral infarct volume and higher
CBF when ventilated using pH- versus a-stat methods.
Arguments also exist in favor of the a-stat method. Propo-
nents of the a-stat method suggest that pH-stat may increase
CBF beyond actual metabolic requirements, which may disrupt
autoregulation, increase cerebral microembolization, and pro-
mote intracranial hypertension (Kofstad, 1996). Furthermore,
the a-stat method theoretically maintains electrochemical
neutrality (i.e., constant [H+]:[OH-]) during hypothermia im-
portant for cellular functions (Laussen et al., 2002). Other data
suggest less cognitive dysfunction following cardiopulmonary
bypass operations using the a-stat than pH-stat (Murkin et al.,
1995). Finally, temperature correction may add an unnecessary
layer of complexity if there is no clinical advantage to pH-stat
management.
The clinical effect of pH-stat versus a-stat in OHCA pa-
tients with ROSC treated with hypothermia has not been
adequately reported. Voicu et al. (2014) reported differences
in jugular vein blood saturation, cerebral oxygen extraction,
and CBF between groups, but did not compare clinical out-
comes between TC strategies, given their crossover study
design. Eastwood et al. (2015) reported that the TC method
influences blood gas readings, unsurprising since a mathe-
matical formula converts the two methods. They generally
found no significant differences in outcomes according to
whether patients treated with a-stat management would have
been classified differently had the pH-stat method been used.
Their methods state that they use a-stat (but not pH-stat)
clinically; therefore, their study does not actually explore the
effect of practice variability in clinical care between these
two methods as we have done, and 26% of their subjects were
not actually cooled.
The relevance of temperature correction may change in the
future, given recent data from the TTM trial suggesting that a
targeted temperature management at 36C conveys the same
Table 3. Arterial Blood Gas Measurements
Impact of corrections
(before–after)a No TC group Intermediate TC group Mostly TC group p-Valueb
pH - 0.05 (-0.06, -0.03) 7.34 (7.32, 7.35) 7.36 (7.33, 7.40) 7.36 (7.34, 7.39) 0.14
CO2 5.7 (2.9, 8.5) 40.0 (38.1, 41.1) 33.6 (30.5, 36.7) 34.0 (31.8, 36.2) < 0.0001
O2 17 (12, 21) 120 (112, 128) 111 (93, 129) 106 (94, 119) 0.2
HCO3 NA 21.0 (20.0, 21.9) 19.2 (17.2, 21.1) 19.78 (18.37, 21.18) 0.17
Readings are displayed as mean (95% confidence interval).
aFrom analysis of change score with repeated measures (uses only subjects with correction).
bFrom main effect of group using mixed procedure with repeated measures and time as linear (uses all subjects).
Table 4. Neurological Outcomes
na
Favorable
outcome, n (%)
Unadjusted,
OR (95% CI)
Adjusted,
OR (95% CI)b
Hospital survival
No TC group 72 28 (39) 1 (Ref) 1 (Ref)
Intermediate TC group 17 2 (12) 0.21 (0.04–0.99) 0.07 (0.01–0.56)
Mostly TC group 33 18 (55) 1.9 (0.82–4.3) 0.53 (0.15–1.9)
Discharge CPC
No TC group 71 15 (21) 1 (Ref) 1 (Ref)
Intermediate TC group 17 2 (12) 0.50 (0.10–2.4) 0.51 (0.06–4.5)
Mostly TC group 33 14 (42) 2.8 (1.1–6.7) 2.1 (0.52–8.8)
Follow-up CPC
No TC group 65 16 (25) 1 (Ref) 1 (Ref)
Intermediate TC group 17 2 (12) 0.41 (0.08–2.0) 0.20 (0.02–2.1)
Mostly TC group 31 15 (48) 2.9 (1.2–7.1) 1.5 (0.33–6.9)
an not always 72 and 33 for a- and pH-stat groups due to missing values.
bAdjusted for whether presenting rhythm was shockable, age, sex, history of diabetes, history of CHF, APACHE II score, etiology, and ICU.
CI, confidence interval; CPC, cerebral performance category; ICU, intensive care unit; OR, odds ratio.
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level of neuroprotection as a target of 33C (Nielsen et al.,
2013).
Our study has a number of limitations. We do not have
available exactly what ventilator changes were made in re-
sponse to each blood gas for all patients. However, our in-
stitution does have a standard ventilator protocol whereby
respiratory rate and/or tidal volumes were adjusted to achieve
a normal pH using either the uncorrected values when no
corrected values were available or the corrected values when
corrected values were available. The fact that TC has a sta-
tistically significant change on pH and yet pH is similar
across groups (Table 3) supports that clinicians reacted ap-
propriately at the bedside to achieve the same targeted acid/
base values across groups based on the available gases.
Presumably, similar pH readings in the no TC versus the
mostly TC groups actually reflect that the mostly TC was in
reality slightly more acidic than the no TC group, since TC
makes a gas appear more basic. Therefore, in theory, there
was in fact a physiological difference between groups that we
may use to test whether such a physiological difference was
correlated with outcomes, although this relationship is com-
plex. Another limitation is the retrospective nature of out-
come measures and the limited numbers of patients in this
study leading to a high risk of bias. CPCs were based on the
electronic medical records review, which although a common
practice in cardiac arrest literature, may fall short compared
with a prospective more detailed neurological assessment.
Our study has a number of strengths. Our study design and
primary outcomes build upon previous reports, which used
animal models, physiological surrogate patient endpoints,
and retrospective group classification. We have done so by
using practice variability to assess differences in multiple
clinically meaningful patient outcomes. In addition, we in-
cluded a range of etiologies (both cardiac and noncardiac),
rhythms (shockable and nonshockable), and ICUs to explore
a wider range of practice space, which increases the gener-
alizability of our study.
Conclusion
There was substantial practice variability in the tempera-
ture correction strategy. Availability of TC ABGs was not
associated with improved neurological outcomes after ad-
justing for covariates.
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